Dr Emily Gulliver is a postdoctoral scientist in the Microbiota and Systems Biology Laboratory within the Centre for Innate Immunity and Infectious Diseases. Dr Gulliver completed her PhD with A/Prof John Boyce at Monash University where she studied small RNA regulation within the Gram-negative bacterial pathogen Pasteurella multocida. This work identified the role of the sRNA GcvB in amino acid biosynthesis and transport and elucidated the RNA binding partners of the sRNA chaperone protein ProQ within P. multocida. Since 2019, Dr Gulliver has been working on developing microbiological, genomic and sequencing methods to characterise the movement of antimicrobial resistance genes between bacteria that inhabit the human gut.

Selected publications

• Gulliver EL, Wright A, Deveson Lucas D, Mégroz M, Kleifeld O, Schittenhelm R, Powell D, Seemann T, Bulitta J, Harper M, Boyce J (2018) Determination of the small RNA GcvB regulon in the Gram-negative bacterial pathogen Pasteurella multocida and identification of the GcvB seed binding region. RNA 24: 704-720.

• James KR, Gomes T, Elmentaite R, Kumar N, Gulliver EL, King HW, Stares MD, Bareham BR, Ferdinand JR, Petrova VN, Polański K, Forster SC, Jarvis LB, Suchanek
  O, Howlett S, James LK, Jones JL, Meyer KB, Clatworthy MR, Saeb-Parsy K, Lawley TD, Teichmann SA (2020) Distinct microbial and immune niches of the human colon. Nat Immunology 21 (3): 343-353.

• Gulliver, EL, Young, RB, Chonwerawong, M, D’Adamo, GL, Thomason, T, Widdop, JT, et al. Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther. 56, 192 – 208 (2022). https://doi.org/10.1111/apt.17049